References

An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015. J Am Acad Dermatol 78(1):47-53.

Skin biopsy utilization and melanoma incidence among Medicare beneficiaries. Br J Dermatol 176(4): 949-954.

Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol 62(5):751-756.

Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 27(6):528-531.

Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ 357: j2813.

Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas. Am J Dermatopathol 34(1): 82-90.

Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms. J Am Acad Dermatol 75(6): 1176-1186.

MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (Review). Int J Oncol 46(3):893-906.

MALDI imaging mass spectrometry: current frontiers and perspectives in pathology research and practice. Lab Invest 95(4):422-431.

Imaging of intact tissue sections: moving beyond the microscope. J Biol Chem 286(29): 25459-25466.

Histology-guided high-resolution matrix-assisted laser desorption ionization mass spectrometry imaging. Anal Chem 87(24):11978-11983.